Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HELE has now passed its October 8 earnings release with short sellers still holding a meaningful position, the stock down 7% on the week, and the borrow market offering no sign of squeeze pressure.
Short interest came into the print at 12.6% of the free float, a genuinely elevated level, and it has barely moved. The week-on-week change is just 0.17%, with the month-on-month build running at 3%. Days to cover sits near nine, which means any sustained upward move would take time to absorb. The borrow side, however, tells a different story. Availability is extremely loose at 890%, meaning there are roughly nine shares available to lend for every one already borrowed. The cost to borrow has fallen 33% over the week to 0.52%. New shorts face minimal friction, and nothing in the lending market suggests bears are being squeezed out.
Options positioning remains equally unremarkable. The put/call ratio is 0.75, fractionally below its 20-day average of 0.75, and the z-score of -0.87 places it well within normal range. There is no elevated demand for downside protection. That combination, high short interest and relaxed options sentiment, was the notable feature heading into the print and remains so coming out of it.
The Street's view is cautious but not hostile. Canaccord Genuity raised its target to $26 from $25 on October 6, maintaining a Hold rating, which places it barely above the current price of $25.55. The analyst consensus mean target is $31.33, implying roughly 23% upside from here, but that aggregate reflects a mix of staleness and hesitation rather than conviction. UBS and Canaccord have both been raising and cutting targets throughout 2026 without changing their neutral stances. No analyst on the register is arguing for a re-rating. The EV/EBITDA multiple is running near 7.2x, and the price-to-book is 0.61x. The ORTEX EV/EBIT factor scores in the 72nd percentile, meaning value metrics look relatively cheap within the universe, but the short score rank of 13 flags that bears are more concentrated here than in most comparable names.
The bull and bear cases from the Benzinga summary capture the core tension. On the positive side, management has reported point-of-sale unit growth across eight of eleven key brands, DTC is growing, and the company is implementing selective price increases to protect margins. On the negative side, the projected revenue decline is around 10%, driven by weaker consumer demand in beverageware and home categories, tariff-related order cancellations, and ongoing pressure in hair appliances and fan sales. The closeout channel has weakened, and distribution losses are compounding the top-line headwind.
Institutional flows offer one notable data point. BlackRock added 137,000 shares in the most recent reporting period, lifting its stake to 8.1% of shares. AQR Capital built a 5.6% position over the summer. Dimensional Fund Advisors added 194,000 shares. These are passive and quant-driven buyers, but the accumulation adds a counterweight to the short book. FMR, by contrast, disclosed a near-total exit from a prior 11.3% stake, a substantial reduction that was filed in August 2025. The 13D/G register carries no activist presence; all holders are on passive Schedule 13G filings, and stakes are as-last-disclosed around the 5% threshold.
The next focus for HELE is how management's commentary on the cold-and-flu season and tariff exposure translates into forward guidance, given that the print itself now provides the first concrete data against which analyst targets can be recalibrated.
See the live data behind this article on ORTEX.
Open HELE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
